Samiksha Jaiswal (Editor)

Emery–Dreifuss muscular dystrophy

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Specialty
  
neurology

ICD-9-CM
  
359.0-359.1

DiseasesDB
  
31705 3354331704

ICD-10
  
G71.0

OMIM
  
181350 604929 310300

eMedicine
  
neuro/513

Emery–Dreifuss muscular dystrophy

Emery–Dreifuss muscular dystrophy is a condition that mainly affects muscles used for movement, such as skeletal muscles and also affects the cardiac muscle, it is named after Alan Eglin H. Emery and Fritz E. Dreifuss.

Contents

Classification

The types of Emery–Dreifuss muscular dystrophy are distinguished by their pattern of inheritance: X-linked, autosomal dominant, and autosomal recessive.

  • Autosomal dominant Emery–Dreifuss muscular dystrophy individuals experience heart problems with weakness (and wasting) of skeletal muscles and Achilles tendon contractures.
  • X-linked Emery–Dreifuss muscular dystrophy is the result of the EMD gene, with cardiac involvement and some mental retardation.
  • Autosomal recessive individuals with this type of the disorder demonstrate cardiac issues, such as arrhythmia. Individuals who acquire EDMD via the autosomal recessive route have an incidence of 1 in 300,000.
  • Symptoms/signs

    Symptoms of EDMD begin in teenage years with toe-walking, rigid spine, face weakness, hand weakness and calf hypertrophy. Among other signs/symptoms of Emery–Dreifuss muscular dystrophy are:

  • Muscle weakness EDMD can affect the shoulders and lower legs
  • Cardiac involvement can affect an individuals heart rate (bradycardia, palpitations)
  • Contractures of the muscles occurs slowly, eventually leading to the need for orthopedics (walker, cane)
  • Genetics

    In terms of genetics, mutations in the EMD and LMNA genes cause Emery–Dreifuss muscular dystrophy. The EMD and LMNA genes provide instructions for making proteins that are components of the nuclear envelope, which surrounds the nucleus in cells. The nuclear envelope regulates the movement of molecules into and out of the nucleus, and researchers believe it may play a role in regulating the activity of certain genes.

    Diagnosis

    The diagnosis of Emery–Dreifuss muscular dystrophy can be established via single-gene testing or genomic testing, and clinically diagnosed via the following exams/methods:

    Treatment

    The treatment (management) of Emery–Dreifuss muscular dystrophy can be done via several methods, however secondary complications should be consider in terms of the progression of EDMD, therefore cardiac defibrillators may be needed at some point by the affected individual. Other possible forms of management and treatment are the following:

  • Orthopaedics
  • Surgery
  • Monitor/treat any cardiac issues
  • Medication (beta-blockers, ACE inhibitors)
  • Respiratory aid
  • Physical therapy
  • References

    Emery–Dreifuss muscular dystrophy Wikipedia


    Similar Topics